|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 810.00 MXN | +43.36% |
|
-.--% | - |
| 06-29 | Zai Lab Insider Sold Shares Worth $428,545, According to a Recent SEC Filing | MT |
| 06-16 | Zai Lab Receives EU Orphan Drug Designation for Lung Cancer Drug | MT |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 0.58% | 0.66% | 17.64x | 1.99x | 3.78x | 9.76x | 11.31x | 67.88B | ||
| 0.6% | 0.61% | 26.33x | 3.98x | 5.45x | 16.01x | 19.85x | 53.23B | ||
| -.--% | -.--% | 37.7x | 7.74x | 12.83x | 24.43x | 28.6x | 48.71B | ||
| 3.5% | 3.59% | -43.2x | 2.42x | 3.1x | 9.18x | 10.71x | 38.98B | ||
| -.--% | -.--% | 24.81x | 1.59x | 3.46x | 11.92x | 13.71x | 29.55B | ||
| -.--% | -.--% | 67.61x | 4.26x | 3.45x | 25.63x | 27.71x | 23.75B | ||
| -.--% | -.--% | -6.42x | 3.89x | 8.92x | -5.49x | -5.13x | 22.07B | ||
| -.--% | 0.05% | 64.54x | 5.8x | 6.33x | 43.58x | 49.16x | 19.84B | ||
| -.--% | -.--% | 24.4x | 3.58x | 5.22x | 13.67x | 18.89x | 16.57B | ||
| -.--% | -.--% | -37.81x | -6.71x | 18.02x | -49.34x | -57.03x | 16.49B | ||
| -.--% | -.--% | -115.63x | 12625.53x | 12.42x | -88.9x | -123.91x | 12.27B | ||
| -.--% | -.--% | 17.84x | - | 3.66x | 14.14x | 16.51x | 11.65B | ||
| 0.16% | 0.17% | 57.08x | 23.28x | 34.59x | 48.92x | 50.45x | 11.38B | ||
| -.--% | -.--% | 47.11x | - | - | - | - | 10.37B | ||
| 2.64% | 3.01% | 13.06x | 1.17x | 1.86x | 7.5x | 10.13x | 6.74B | ||
| 0.37% | 0.43% | 27.84x | - | 7.47x | 19.81x | 23.66x | 5.69B | ||
| 1.62% | 1.75% | 14.09x | 1.25x | 2.4x | 6.33x | 7.57x | 5.44B | ||
| -.--% | -.--% | -110.75x | - | - | - | - | 5.44B | ||
| Average | 0.53% | 0.57% | 7.01x | 905.70x | 8.31x | 6.70x | 6.39x | 22.56B | |
| Weighted average by Cap. | 0.59% | 0.62% | 13.93x | 419.07x | 7.28x | 10.27x | 11.34x |
- Stock Market
- Stocks
- ZLAB Stock
- ZLAB N Stock
- Sector Zai Lab Limited
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
















